影响基因素乙化的化学扰动控制着结直肠癌分化
Pornlada Likasitwatanakul1,2,3,4, Zhixin Li1,2,3, Paul Doan1,3
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
bioRxiv : the preprint server for biology
|December 23, 2024
概括
抑制基因组脱乙酶 (HDAC) 1/2通过改变基因组乙化来促进结直肠癌 (CRC) 的分化和抗瘤活性. 这种表观遗传重编程突出了CRC的潜在治疗策略.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症研究 癌症研究
背景情况:
- 失调的表观遗传程序对结直肠癌 (CRC) 的发展至关重要,促进不受控制的细胞生长和可塑性.
- 基因脱乙酶 (HDACs) 在调节基因表达和细胞分化方面发挥着关键作用.
- 准表观遗传调节器为新型CRC疗法提供了一个有希望的途径.
研究的目的:
- 调查素脱乙酶1/2 (HDAC1/2) 抑制在促进结直肠癌分化中的作用.
- 阐明HDAC1/2抑制诱导的抗瘤活性背后的表观遗传机制.
- 基于表观遗传重编程来确定结直肠癌的潜在治疗策略.
主要方法:
- 使用双记者系统选针对表观遗传调节者的小分子库.
- 生物化学,化学和遗传实验分析HDAC1/2功能和抑制.
- 基因组翻译后修改的概况和基因组范围内的基因组标记的评估 (例如,H3K27ac).
- 单细胞RNA测序和基因查,以识别EP300和DAPK3.3等导致因素.
主要成果:
- 抑制HDAC1/2通过阻断催化域促进结直肠癌分化和抗瘤活性.
- 抑制HDAC1/2导致特定基因组区域的H3K27ac增加,与开放色素和分化基因上调相关.
- EP300的降解挽救了HDAC1/2抑制剂介导的分化,DAPK3有助于这一过程.
- 特定的组织蛋白修饰对于控制癌细胞状态至关重要.
结论:
- 通过诱导分化,HDAC1/2抑制代表了结直肠癌的可行的治疗策略.
- 针对特定的基因组修饰,如H3K27ac,是CRC中的表观遗传重编程的关键.
- 了解表观遗传调节剂和基因素修饰之间的相互作用,可以导致新的癌症治疗方法.
相关概念视频
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
Histone Modification
13.0K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.0K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K


